Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).

about

Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.Progress and promise for the MDMA drug development program.

P2860

Q47662199-58E7FD0D-6681-4FA2-A927-F223F4102357 Q47777762-611B7141-DF33-4F1E-AC4C-9749C7E7C298 Q47963200-365AA263-F09F-4796-BFE0-2D8A5FC93ABD

P2860

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).

Item

http://www.wikidata.org/entity/Q38652284

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inhibition of serotonin transp ...... nedioxymethamphetamine (MDMA).

@en

type

Item

label

Inhibition of serotonin transp ...... nedioxymethamphetamine (MDMA).

@en

prefLabel

Inhibition of serotonin transp ...... nedioxymethamphetamine (MDMA).

@en

P1476

Inhibition of serotonin transp ...... enedioxymethamphetamine (MDMA)

@en

P2093

Barbara O Rothbaum

http://www.w3.org/2001/XMLSchema#string

Boadie W Dunlop

http://www.w3.org/2001/XMLSchema#string

Lara M Khoury

http://www.w3.org/2001/XMLSchema#string

Leonard L Howell

http://www.w3.org/2001/XMLSchema#string

Matthew B Young

http://www.w3.org/2001/XMLSchema#string

Seth D Norrholm

http://www.w3.org/2001/XMLSchema#string

Sheila A M Rauch

http://www.w3.org/2001/XMLSchema#string

Tanja Jovanovic

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders

Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids

Increased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala.

Behavioral and neural analysis of extinction

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

Mechanisms of fear extinction

P2888

s00213-017-4684-8

P304

2883-2895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-017-4684-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

234

http://www.w3.org/2001/XMLSchema#string

P50

Collin Reiff

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090878507

http://www.w3.org/2001/XMLSchema#string

P698

28741031

http://www.w3.org/2001/XMLSchema#string

P921

serotonin

P932

5693755

http://www.w3.org/2001/XMLSchema#string

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).

about

P2860

P2860

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932